Faster global financial news!
BioNTech's lung cancer drug gotistobart shows significant overall survival benefit in Phase 3 trial
BioNTech (NASDAQ:BNTX) reported that its investigational lung-cancer drug gotistobart produced a clinically meaningful overall-survival benefit in the Phase 3 PRESERVE-003 trial for patients with metastatic squamous non-small cell lung cancer. Reuters noted that gotistobart nearly doubled survival compared with standard-of-care chemotherapy, reinforcing its potential as a chemotherapy-free treatment. Earlier Stage 1 data showed a 54% reduction in the risk of death.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Source：Yahoo财经 · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
FUNDZ (FundFantasy) Project Analysis: The Current State of the Blockchain Financial Fantasy Gaming Platform
-
2
DFSM Coin Value Analysis: DFS MAFIA Project Status and Investment Considerations
-
3
TAIL Coin Multi-Entity Analysis: Current Status, Risks, and Development Prospects Assessment
-
4
Austria denied entry to Iranian official Mohammed Eslami after the UN Security Council rejected his request for a travel ban exemption.
-
5
ALIAS Coin: An In-depth Analysis of the Current State and Challenges of Privacy Coin Projects
-
6
Airbloc (ABL) Coin Value Analysis: Project Status and Investment Risk Assessment
-
7
HUM Coin Multi-faceted Analysis: Trading and Listing Platforms for Humanscape, Hum(AI)n Web3, and Hummus
-
8
WLKN Token Analysis: Solana-based Move-to-Earn Project and Its Value Considerations
-
9
Why is Bitcoin thriving but struggling to replace the US dollar's global dominance?
-
10
NCDT (nuco.cloud) Value Analysis and Investment Potential Assessment
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
